Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
-5.04x4.16x0.34x - -5.12x-4.77x - 4.68Cr
45.97x7.26x2.06x10.92x39.12x40.38x0.02% 4.93TCr
18.09x4.33x0.24x6.45x14.35x15.8x1.6% 4.41TCr
-27.24x93x-3.52x62.44x-30.44x-29.42x-.--% 3.49TCr
-27.63x1.26x-1.24x4.79x-13.08x-10.34x-.--% 2.74TCr
33.11x3.07x0.86x6.55x18.16x22.61x-.--% 2.12TCr
19.16x3.63x-5.98x4.92x12.9x13.86x-.--% 2.16TCr
-202.83x24.86x-2.58x48.32x-195.77x-173.36x-.--% 1.39TCr
-459.52x13.39x7.66x29.32x608.28x-489.85x-.--% 1.46TCr
-13.59x - -0.05x170.31x-26.56x-13.29x-.--% 1.36TCr
17.35x4.66x0.36x4.98x12.33x13.6x-.--% 1.22TCr
-48x19.01x0.92x11.52x-44.97x-43.21x-.--% 1.15TCr
-18.71x16.56x-0x20.8x-26.35x-18.91x-.--% 905.8Cr
-163.4x20.27x2.01x18.85x330.82x-130.32x-.--% 766.2Cr
-18.85x8.12x-0.41x - -19.41x-18.75x-.--% 837.46Cr
-10.16x-14.07x-0.49x92.3x-12.43x-12.18x-.--% 789.83Cr
813.26x42.88x-6.75x98.06x882.1x1141.06x - 723.34Cr
Average -2.83x 15.77x -0.39x 39.37x 90.82x 17.82x 0.11% 1.79TCr
Weighted average by Cap. -11.02x 18.42x -0.35x 29.58x 51.32x -3.55x 0.24%
Bio Therapeutic Drugs